Rx-360 Announces the Release of the Rx-360 Supplier Assessment Questionnaire
Rx-360 has announced the release of the Rx-360 Supplier Assessment Questionnaire (SAQ). The SAQ was prepared by the Rx-360 Supplier-Led Working Group, an Rx-360 working group consisting of members from both pharmaceutical companies and leading suppliers to the pharmaceutical industry. Through this Working Group, members can share perspectives and work collaboratively to achieve greater harmonisation and efficiencies in the supply chain to better serve patients.
Pharmaceutical manufacturers and industry suppliers recognise the inefficiency and waste of resources when each individual pharmaceutical company creates its own supplier assessment questionnaire. Suppliers routinely exhaust valuable resources continuously completing slightly different forms of substantially similar questionnaires. To create the current Supplier Assessment Questionnaire, the Working Group analysed numerous sample questionnaires submitted by Rx-360 members. In addition to standardised content, document formatting and question completion was optimised for accuracy and ease of completion by suppliers.
The Rx-360 SAQ covers standard information that would be included in most supplier assessment questionnaires. The 4-part questionnaire is more detailed than most, but will decrease the number of times that questionnaires will need to be filled out by the supplier, while significantly decreasing the turn-around time back to manufacturers. The SAQ consists of four (4) modules:
• General Company Information
• Specific Site Information
• Product Supplier Appendix
• Services Supplier Appendix.
The Working Group believes the Rx-360 SAQ will create helpful efficiencies for both suppliers and pharmaceutical manufactures alike by
• Eliminating time-consuming redundancies
• Streamlining the process of approving suppliers
• Allowing comparative analysis of basic information.
The Supplier Led Working Group strongly encourages suppliers and manufacturers to consider adopting this SAQ in standard use. All modules will be available shortly for public download at the Rx-360 website.
The Supplier Led Working Group will be holding a public webinar to introduce the documents on 28 August 2014.
Anyone interested in learning more or considering use of the questionnaires is encouraged to attend. To RSVP, please register through this link: www4.gotomeeting.com/register/163722479.
Related News
-
News WuXi to sell CGT manufacturing unit to US-based Altaris LLC
At the tail end of 2024, Chinese-based CDMO WuXi AppTec announced the signing of their deal with private equity firm Altaris LLC, confirming the sale of WuXi Advanced Therapies, the cell and gene therapy manufacturing arm of WuXi AppTec. -
News Women in Pharma: Our hopes for 2025 and beyond
Our last instalment for 2024 of the Women in Pharma series brings you messages direct from the Informa Markets CPHI team as they discuss the advice and insights they have carried throughout their roles working at CPHI, and what they hope to see for the... -
News CPHI Milan Wrap-Up Report: Conference Highlights
Discover the emerging and trending topics of the pharmaceutical industry with our CPHI Milan Conference Highlights, with exclusive insight from pharmaceutical leaders and experts! -
News BIOSECURE Act not included in key defense spending bill for 2025
On December 7, 2024, the Biden administration revealed the 2025 National Defense Authorization Act, an annual defense bill specifying the budget and expenditures of the US Department of Defense. The controversial BIOSECURE Act was notably missing from ... -
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News Trump 2.0: What does the US election result mean for the healthcare industry?
After Trump won the Presidential election in the US in early November, we take a look at some of the implications a new Trump administration could have on the health and pharmaceutical industry, and on US patients. -
News Women in Pharma: Reflections from Behind the Scenes
In this instalment of our monthly series, the team that brings you the Women in Pharma series each month sits down for a heart-to-heart on what the series means to them, and how they hope to continue their work in the future. -
News Scaling the Industry: CPHI Scale-Up Market interview with YSK Laboratories
For the first time, CPHI Milan hosted the CPHI Start-Up Market, expanding support for emerging and small-sized enterprises in their transition to the next level of growth. In this interview, we spoke with Yuvansh Khokhani, Managing Director of YSK Labo...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance